ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

A1LN34 Alnylam Pharmaceuticals Inc

38.92
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 3.43B3.33B3.54B3.55B3.39B3.4B3.84B3.83B
Total Current Assets 2.59B2.47B2.69B2.69B2.54B2.52B2.99B2.98B
Cash and Equivalents 534.08M575.56M1.07B866.39M672.25M657.8M1.03B812.69M
Total Non-Current Assets 843.87M858.78M1.36B1.38B850.92M878.35M853.62M1.37B
Total Liabilities 3.03B3.15B3.6B3.7B3.65B3.81B4B4.05B
Total Current Liabilities 605.96M657.69M772.79M767.92M673.39M788.64M949.79M967.79M
Total Non-Current Liabilities 3.1B3.17B3.85B3.95B4B4.04B4.07B4.1B
Common Equity 1.21M1.21M1.23M1.24M1.24M1.25M1.26M1.26M
Retained Earnings -5.68B-5.96B-6.36B-6.57B-6.74B-7.02B-6.87B-7.01B
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.26B1.99B1.57B2.4B3.41B3.64B3.55B3.83B
Total Current Assets 671.88M1.76B1.2B1.72B2.61B2.81B2.69B2.98B
Cash and Equivalents 193.62M645.36M420.15M547.18M496.58M819.98M866.39M812.69M
Total Non-Current Assets 920.22M1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M
Total Liabilities 342.59M228.3M272.84M956.44M2.39B3.06B3.7B4.05B
Total Current Liabilities 131.7M144.25M179.49M352.59M585.27M695.71M767.92M967.79M
Total Non-Current Liabilities 360.89M114.05M123.34M603.85M2B3.04B3.95B4.1B
Total Equity 920.22M1.77B1.3B1.44B1.02B588.2M-158.22M-220.64M
Common Equity 859k997k1.01M1.12M1.16M1.2M1.24M1.26M
Retained Earnings -1.66B-2.15B-2.84B-3.73B-4.59B-5.44B-6.57B-7.01B